Vasowatch

Vasowatch

Series

Unknown

Wearable risk detector for postpartum hemorrhage

Wearable risk detector for postpartum hemorrhage

FOUNDED

FOUNDED

2021

2021

TOTAL FUNDING

TOTAL FUNDING

TOTAL FUNDING

$752K

$752K

LATEST STAGE

LATEST STAGE

Seed

Seed

Unknown

Unknown

HEADCOUNT

HEADCOUNT

1-10

1-10

PRODUCT OVERVIEW

Vasowatch is a non-invasive wearable system and algorithmic decision support tool that continuously monitors maternal heart rate patterns to detect myometrial fatigue, a predictive biomarker for postpartum hemorrhage (PPH). By streaming data from ECG or PPG wearables into its VIBRANT algorithm, the platform updates a real-time risk status and sends alerts to bedside and care team dashboards thus providing hours of advance warning before delivery. Vasowatch's observational study demonstrated up to ten times the sensitivity of current admission risk tools, with statistically significant improvements detected six hours before delivery making it the first tool of its kind to predict PPH physiologically rather than by patient history.

Show more

NURSE FOUNDER

COMPANY INFO

Status

Active

HQ

Philadelphia, PA

Category

Clinical Software

Profile claimed?

Unclaimed

INVESTORS

Lead

Laerdal Million Lives Fund

mHUB Product Impact Fund, Raynier Seed Fund, MATTER Health

ACCELERATORS

PRODUCT OVERVIEW

Vasowatch is a non-invasive wearable system and algorithmic decision support tool that continuously monitors maternal heart rate patterns to detect myometrial fatigue, a predictive biomarker for postpartum hemorrhage (PPH). By streaming data from ECG or PPG wearables into its VIBRANT algorithm, the platform updates a real-time risk status and sends alerts to bedside and care team dashboards thus providing hours of advance warning before delivery. Vasowatch's observational study demonstrated up to ten times the sensitivity of current admission risk tools, with statistically significant improvements detected six hours before delivery making it the first tool of its kind to predict PPH physiologically rather than by patient history.

FUNDING TIMELINE

Funding timeline here

Funding timeline here

IN THE NEWS

NURSE FOUNDER

COMPANY INFO

Status

Active

HQ

Philadelphia, PA

Category

Clinical Software

Profile claimed?

Unclaimed

INVESTORS

Lead

Laerdal Million Lives Fund

mHUB Product Impact Fund, Raynier Seed Fund, MATTER Health